Article
Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance
9 Jun 2021
Abstract excerpt
Androgen receptor (AR), a ligand-dependent nuclear transcription factor and a member of steroid hormone receptor family, plays an important role in prostate organogenesis by regulating epithelial differentiation and restricting cell proliferation. Although rarely mutated or amplified in treatment-naïve prostate cancer (PCa), AR signaling drives tumor growth and as a result, therapies that aim to inhibit AR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
